Ampio Pharmaceuticals Inc (AMPE)
0.24
-0.01
(-4.00%)
USD |
OTCM |
Apr 18, 13:54
Ampio Pharmaceuticals Free Cash Flow: -8.564M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.564M |
| September 30, 2023 | -10.55M |
| June 30, 2023 | -15.94M |
| March 31, 2023 | -18.48M |
| December 31, 2022 | -21.13M |
| September 30, 2022 | -20.54M |
| June 30, 2022 | -18.50M |
| March 31, 2022 | -14.89M |
| December 31, 2021 | -14.19M |
| September 30, 2021 | -13.38M |
| June 30, 2021 | -12.20M |
| March 31, 2021 | -14.47M |
| December 31, 2020 | -14.79M |
| September 30, 2020 | -16.66M |
| June 30, 2020 | -18.64M |
| March 31, 2020 | -17.51M |
| December 31, 2019 | -15.40M |
| September 30, 2019 | -13.05M |
| June 30, 2019 | -11.57M |
| March 31, 2019 | -11.36M |
| December 31, 2018 | -12.70M |
| September 30, 2018 | -12.91M |
| June 30, 2018 | -12.80M |
| March 31, 2018 | -12.63M |
| December 31, 2017 | -11.48M |
| Date | Value |
|---|---|
| September 30, 2017 | -11.45M |
| June 30, 2017 | -10.80M |
| March 31, 2017 | -12.38M |
| December 31, 2016 | -14.62M |
| September 30, 2016 | -19.81M |
| June 30, 2016 | -23.59M |
| March 31, 2016 | -24.39M |
| December 31, 2015 | -26.55M |
| September 30, 2015 | -25.30M |
| June 30, 2015 | -27.81M |
| March 31, 2015 | -34.93M |
| December 31, 2014 | -39.41M |
| September 30, 2014 | -38.93M |
| June 30, 2014 | -35.54M |
| March 31, 2014 | -28.09M |
| December 31, 2013 | -20.77M |
| September 30, 2013 | -17.34M |
| June 30, 2013 | -13.85M |
| March 31, 2013 | -10.82M |
| December 31, 2012 | -9.715M |
| September 30, 2012 | -11.25M |
| June 30, 2012 | -10.92M |
| March 31, 2012 | -10.54M |
| December 31, 2011 | -9.216M |
| September 30, 2011 | -5.825M |
Free Cash Flow Range, Past 5 Years
-21.13M
Minimum
Dec 2022
-8.564M
Maximum
Dec 2023
-15.29M
Average
-14.89M
Median
Mar 2022
Free Cash Flow Benchmarks
| NeuBase Therapeutics Inc | -14.85M |
| Tivic Health Systems Inc | -8.629M |
| Oragenics Inc | -7.291M |
| Actinium Pharmaceuticals Inc | -47.49M |
| MAIA Biotechnology Inc | -13.07M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.309M |
| Free Cash Flow Per Share (Quarterly) | -2.789 |
| Free Cash Flow Yield | -4.54K% |